EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹160 Cr | ₹138 Cr | ₹113 Cr | ₹77 Cr | ₹74 Cr |
What is the latest Total Current Liabilities ratio of EVEREST ORGANICS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹160 Cr |
Mar2023 | ₹138 Cr |
Mar2022 | ₹113 Cr |
Mar2021 | ₹77 Cr |
Mar2020 | ₹74 Cr |
How is Total Current Liabilities of EVEREST ORGANICS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹160 Cr | 16.37 | |
Mar2023 | ₹138 Cr | 22.23 | |
Mar2022 | ₹113 Cr | 45.50 | |
Mar2021 | ₹77 Cr | 4.53 | |
Mar2020 | ₹74 Cr | - |
Compare Total Current Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹394.6 Cr | -1.4% | -1.4% | 185.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -1.4% |
-1.4% |
185.4% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses